FDA Drug Application (202254) for IRBESARTAN by MACLEODS PHARMS LTD

Back to FDA Applications sponsored by MACLEODS PHARMS LTD

Application Number202254
Product Number001
FormTABLET;ORAL
Dosage75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameIRBESARTAN
Active IngredientIRBESARTAN

Active IngredientCount
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by MACLEODS PHARMS LTD